Sign Out
Use in Pregnancy: Adequate data from treatment of pregnant women is missing.
Lidocaine passes the placenta.
It is reasonable to assume that a large number of pregnant women and women of child-bearing age have been given lidocaine. No specific disturbances to the reproductive process have so far been reported, e.g. no increased incidence of malformations, or direct or indirect effect on the foetus. However, the risks for human are not completely investigated.
Animal studies are incomplete regarding effects on pregnancy, embryonal/foetal development, childbirth and development after birth (see Pharmacology: Toxicology: Preclinical Safety Data under Actions).
At temporary use of Xylocaine 2% Jelly during pregnancy the benefit is judged to overweigh the possible risks.
Use in Lactation: Lidocaine is excreted into mother's milk in small amounts. The use of Xylocaine 2% Jelly at recommended doses is unlikely to affect the neonate. Breastfeeding can therefore be continued during use of Xylocaine 2% Jelly.
